14.45
+0.06
(0.42%)
May 21 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 14.19 - 14.68 |
| 52 week | 9.13 - 16.29 |
| Open | 14.35 |
| Vol / Avg. | 42,015.00/69,873.00 |
| Mkt cap | 202.39M |
| P/E | 16.09 |
| Div/yield | - |
| EPS | 0.90 |
| Shares | 14.01M |
| Beta | 1.47 |
| Inst. own | 47% |
Events
Jul 30, 2013
Q2 2013 Anika Therapeutics Earnings Release
Jun 18, 2013
Anika Therapeutics Annual Shareholder Meeting
- 11:30AM EDT -
May 3, 2013
Q1 2013 Anika Therapeutics Earnings Release
May 2, 2013
Q1 2013 Anika Therapeutics Earnings Conference Call -
Mar 19, 2013
Anika Therapeutics at Canaccord Genuity Musculoskeletal Conference
Feb 28, 2013
Q4 2012 Anika Therapeutics Earnings Conference Call -
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 20.12% | 16.48% |
| Operating margin | 32.87% | 27.63% |
| EBITD margin | - | 37.53% |
| Return on average assets | 8.68% | 8.55% |
| Return on average equity | 11.10% | 11.54% |
| Employees | 106 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Anika Therapeutics, Inc. (Anika) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. As of December 31, 2011, Anika�s wholly owned subsidiary, Anika Therapeutics S.r.l., had over 20 products commercialized, primarily in Europe. These products are also all made from hyaluronic acid, based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
Officers and directors
| Charles H. Sherwood Ph.D. | President, Chief Executive Officer, Director | |
| Sylvia Cheung | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer, Secretary | |
| Frank J. Luppino | Chief Operating Officer | |
| William J. Mrachek | Vice President - Human Resources | |
| Joseph L. Bower Ph.D. | Lead Independent Director | |
| Raymond J. Land | Independent Director | |
| John C. Moran | Independent Director | |
| Jeffery S. Thompson | Independent Director | |
| Steven E. Wheeler | Independent Director |